CRB
Chad R. Baker Portfolio holdings
AUM
$538M
This Quarter Return
+6.29%
1 Year Return
+20.8%
3 Year Return
+87.18%
5 Year Return
+140.51%
10 Year Return
–
AUM
$470M
AUM Growth
+$470M
(+5.7%)
Cap. Flow
+$8M
Cap. Flow
% of AUM
1.7%
Top 10 Holdings %
Top 10 Hldgs %
45.17%
Holding
54
New
1
Increased
15
Reduced
11
Closed
1
Top Buys
| 1 |
Walmart
WMT
|
$4.13M |
| 2 |
Veralto
VLTO
|
$1.81M |
| 3 |
Alcon
ALC
|
$1.71M |
| 4 |
McCormick & Company Non-Voting
MKC
|
$432K |
| 5 |
Aptiv
APTV
|
$337K |
Top Sells
| 1 |
Mastercard
MA
|
$568K |
| 2 |
Unilever
UL
|
$202K |
| 3 |
Amazon
AMZN
|
$79.4K |
| 4 |
NVIDIA
NVDA
|
$45.2K |
| 5 |
Advanced Micro Devices
AMD
|
$22.6K |
Sector Composition
| 1 | Technology | 32.29% |
| 2 | Industrials | 19.05% |
| 3 | Healthcare | 18.38% |
| 4 | Consumer Discretionary | 12.18% |
| 5 | Communication Services | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Lowe's Companies
LOW
$145B
| $7.16M | 1.52% |
28,100
| – | – |
|
27
Stryker
SYK
$149B
| $6.85M | 1.46% |
19,145
| – | – |
|
28
Home Depot
HD
$406B
| $6.76M | 1.44% |
17,635
+70
| +0.4% | +$26.9K |
|
29
CRISPR Therapeutics
CRSP
$4.74B
| $6.72M | 1.43% |
98,520
| – | – |
|
30
TJX Companies
TJX
$154B
| $6.32M | 1.35% |
62,340
+410
| +0.7% | +$41.6K |
|
|
31
Walmart
WMT
$778B
| $6.2M | 1.32% |
103,020
+68,680
| +200% | +$4.13M |
|
32
New York Times
NYT
$9.53B
| $6.19M | 1.32% |
143,325
| – | – |
|
|
33
Veralto
VLTO
$26B
| $5.95M | 1.27% |
67,112
+20,422
| +44% | +$1.81M |
|
34
Colgate-Palmolive
CL
$68B
| $4.61M | 0.98% |
51,200
| – | – |
|
35
Adobe
ADBE
$146B
| $4.54M | 0.97% |
9,000
| – | – |
|
36
Zoetis
ZTS
$67.4B
| $4.2M | 0.89% |
24,818
| – | – |
|
37
CSX Corp
CSX
$59.9B
| $3.78M | 0.81% |
102,000
| – | – |
|
38
RTX Corp
RTX
$211B
| $3.74M | 0.8% |
38,348
| – | – |
|
|
WIRE
39
DELISTED
Encore Wire Corp
WIRE
| $3.42M | 0.73% |
13,000
| – | – |
|
|
40
Alcon
ALC
$38.7B
| $3.4M | 0.72% |
40,795
+20,530
| +101% | +$1.71M |
|
41
Alphabet (Google) Class C
GOOG
$2.53T
| $3.36M | 0.72% |
22,100
+10
| +0% | +$1.52K |
|
42
Merck
MRK
$213B
| $2.86M | 0.61% |
21,700
| – | – |
|
43
Cigna
CI
$80.4B
| $2.12M | 0.45% |
5,841
| – | – |
|
44
Exxon Mobil
XOM
$490B
| $1.91M | 0.41% |
16,400
| – | – |
|
45
Canadian National Railway
CNI
$60.2B
| $1.75M | 0.37% |
13,275
-25
| -0.2% | -$3.29K |
|
46
Fortive
FTV
$15.8B
| $1.29M | 0.27% |
15,000
| – | – |
|
|
47
NVIDIA
NVDA
$4.11T
| $989K | 0.21% |
1,095
-50
| -4% | -$45.2K |
|
|
48
Aptiv
APTV
$17B
| $814K | 0.17% |
10,220
+4,225
| +70% | +$337K |
|
49
Novo Nordisk
NVO
$249B
| $691K | 0.15% |
5,380
| – | – |
|
50
Pfizer
PFE
$141B
| $680K | 0.14% |
24,500
| – | – |
|